Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe

On the basis of scientific evidence, information on the option, recommendation or requirement to test for pharmacogenetic or pharmacogenomic biomarkers is incorporated in the Summary of Product Characteristics of an increasing number of drugs in Europe. A screening of the Genetic Testing Registry (G...

Descripción completa

Detalles Bibliográficos
Autores principales: Huebner, Tatjana, Steffens, Michael, Scholl, Catharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766366/
https://www.ncbi.nlm.nih.gov/pubmed/34905151
http://dx.doi.org/10.1007/s40291-021-00567-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766366/
https://www.ncbi.nlm.nih.gov/pubmed/34905151
http://dx.doi.org/10.1007/s40291-021-00567-x

Ejemplares similares